Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $33

Benzinga · 3d ago
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $39 to $33.